404 related articles for article (PubMed ID: 24615308)
1. Barriers to primary care physicians prescribing buprenorphine.
Hutchinson E; Catlin M; Andrilla CH; Baldwin LM; Rosenblatt RA
Ann Fam Med; 2014; 12(2):128-33. PubMed ID: 24615308
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
Jones CM; McCance-Katz EF
Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adopters.
Quest TL; Merrill JO; Roll J; Saxon AJ; Rosenblatt RA
J Opioid Manag; 2012; 8(1):29-38. PubMed ID: 22479882
[TBL] [Abstract][Full Text] [Related]
4. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.
Andrilla CHA; Moore TE; Patterson DG
J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720
[TBL] [Abstract][Full Text] [Related]
5. A survey of barriers and facilitators to the adoption of buprenorphine prescribing after implementation of a New Jersey-wide incentivized DATA-2000 waiver training program.
Nyaku AN; Zerbo EA; Chen C; Milano N; Johnston B; Chadwick R; Marcello S; Baston K; Haroz R; Crystal S
BMC Health Serv Res; 2024 Feb; 24(1):179. PubMed ID: 38331802
[TBL] [Abstract][Full Text] [Related]
6. Practice Predictors of Buprenorphine Prescribing by Family Physicians.
Peterson LE; Morgan ZJ; Borders TF
J Am Board Fam Med; 2020; 33(1):118-123. PubMed ID: 31907252
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine Prescribing and Challenges Faced Among National Health Service Corps Clinicians.
Rowan K; Shah SV; Binns S; Murphy E; Satorius J; Ghobadi A; Krauss D; Robbins C; Schoebel V; Knudson A; Kepley H;
JAMA Netw Open; 2024 May; 7(5):e2411742. PubMed ID: 38758556
[TBL] [Abstract][Full Text] [Related]
8. A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
Haffajee RL; Andraka-Christou B; Attermann J; Cupito A; Buche J; Beck AJ
Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):69. PubMed ID: 32928272
[TBL] [Abstract][Full Text] [Related]
9. Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine.
Andrilla CHA; Jones KC; Patterson DG
J Rural Health; 2020 Mar; 36(2):187-195. PubMed ID: 31650634
[TBL] [Abstract][Full Text] [Related]
10. Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.
Andrilla CHA; Coulthard C; Larson EH
Ann Fam Med; 2017 Jul; 15(4):359-362. PubMed ID: 28694273
[TBL] [Abstract][Full Text] [Related]
11. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers.
Walley AY; Alperen JK; Cheng DM; Botticelli M; Castro-Donlan C; Samet JH; Alford DP
J Gen Intern Med; 2008 Sep; 23(9):1393-8. PubMed ID: 18592319
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine Waiver Attitudes Among Primary Care Providers.
Lai B; Croghan I; Ebbert JO
J Prim Care Community Health; 2022; 13():21501319221112272. PubMed ID: 35822763
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine prescribing practice trends and attitudes among New York providers.
Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
[TBL] [Abstract][Full Text] [Related]
14. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
[TBL] [Abstract][Full Text] [Related]
15. Empowering Psychiatric Mental Health Nurse Practitioners to Expand Treatment Opportunities for Veterans With Opioid Use Disorder.
Jones J; Tierney M; Jacobs G; Chien SY; Mallisham S
J Addict Nurs; 2020; 31(4):261-268. PubMed ID: 33264198
[TBL] [Abstract][Full Text] [Related]
16. Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.
Andrilla CHA; Coulthard C; Patterson DG
Am J Prev Med; 2018 Jun; 54(6 Suppl 3):S208-S214. PubMed ID: 29779544
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of the evaluation of the California Hub and Spoke Program.
Darfler K; Sandoval J; Pearce Antonini V; Urada D
J Subst Abuse Treat; 2020 Jan; 108():26-32. PubMed ID: 31400985
[TBL] [Abstract][Full Text] [Related]
18. Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.
Peterson LE; Morgan ZJ; Eden AR
J Am Board Fam Med; 2020; 33(1):7-8. PubMed ID: 31907240
[TBL] [Abstract][Full Text] [Related]
19. To Prescribe or Not to Prescribe?: Barriers and Motivators for Progressing Along Each Stage of the Buprenorphine Training and Prescribing Path.
Winograd RP; Coffey B; Woolfolk C; Wood CA; Ilavarasan V; Liss D; Jain S; Stringfellow E
J Behav Health Serv Res; 2023 Apr; 50(2):165-180. PubMed ID: 35060002
[TBL] [Abstract][Full Text] [Related]
20. Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic.
James JR; Gordon LM; Klein JW; Merrill JO; Tsui JI
Subst Abus; 2019; 40(1):11-13. PubMed ID: 29578857
[No Abstract] [Full Text] [Related]
[Next] [New Search]
